Report Detail
Induced Pluripotent Stem Cells (iPSCs)-Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Market Status and Trend Report 2013-2026
- RnM3781267 |
- 25 September, 2019 |
- Global |
- 127 Pages |
- Owlreports |
- Pharma & Healthcare
Report Summary:
The report titled "Induced Pluripotent Stem Cells (iPSCs) Market" offers a primary overview of the Induced Pluripotent Stem Cells (iPSCs) industry covering different product definitions, classifications, and participants in the industry chain structure. The quantitative and qualitative analysis is provided for the global Induced Pluripotent Stem Cells (iPSCs) market considering competitive landscape, development trends, and key critical success factors (CSFs) prevailing in the Induced Pluripotent Stem Cells (iPSCs) industry.
Historical Forecast Period
2013 - 2017 – Historical Year for Induced Pluripotent Stem Cells (iPSCs) Market
2018 – Base Year for Induced Pluripotent Stem Cells (iPSCs) Market
2019-2026 – Forecast Period for Induced Pluripotent Stem Cells (iPSCs) Market
Key Developments in the Induced Pluripotent Stem Cells (iPSCs) Market
To describe Induced Pluripotent Stem Cells (iPSCs) Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
To analyze the manufacturers of Induced Pluripotent Stem Cells (iPSCs), with profile, main business, news, sales, price, revenue and market share in 2016 and 2018;
To display the competitive situation among the top manufacturers in Global, with sales, revenue and market share in 2016 and 2018;
To show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2013 to 2019;
To analyze the key countries by manufacturers, Type and Application, covering North America, Europe, Asia Pacific, Middle-East and South America, with sales, revenue and market share by manufacturers, types and applications;
Induced Pluripotent Stem Cells (iPSCs) market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2019 to 2026;
To analyze the manufacturing cost, key raw materials and manufacturing process etc.
To analyze the industrial chain, sourcing strategy and downstream end users (buyers);
To describe Induced Pluripotent Stem Cells (iPSCs) sales channel, distributors, traders, dealers etc.
To describe Induced Pluripotent Stem Cells (iPSCs) Research Findings and Conclusion, Appendix, methodology and data source
Market Segment by Manufacturers, this report covers
• Fujifilm Holding Corporation (CDI)
• ReproCELL
• Astellas Pharma Inc
• Ncardia
• Cell Inspire Biotechnology
• Sumitomo Dainippon Pharma
• Pluricell Biotech
• Fate Therapeutics, Inc
Market Segment by Countries, covering
• North America (United States, Canada, Mexico) Market Revenue and/or Volume
Europe (Germany, UK, France, Russia, Italy) Market Revenue and/or Volume
Asia Pacific (China, Japan, Korea, India, Southeast Asia) Market Revenue and/or Volume
Middle-East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) Market Revenue and/or Volume
South America (Brazil, Argentina, Colombia) Market Revenue and/or Volume
Market Segment by Type, covers
• Human iPSCs
• Mouse iPSCs
Market Segment by Applications, can be divided into
• Academic Research
• Drug Development and Discovery
• Toxicity Screening
• Regenerative Medicine
_x000C_
Table of Contents
1. Methodology and Scope
- 1.1. Methodology
- 1.1.1. Initial data exploration
- 1.1.2. Statistical model and forecast
- 1.1.3. Industry insights and validation
- 1.1.4. Definitions forecast parameters
- 1.2. Data sources
- 1.2.1. Secondary
- 1.2.2. Primary
2 Market Overview
- 2.1 Induced Pluripotent Stem Cells (iPSCs) Introduction
- 2.2 Market Analysis by Type
- 2.2.1 Human iPSCs
- 2.2.2 Mouse iPSCs
- 2.3 Market Analysis by Applications
- 2.3.1 Academic Research
- 2.3.2 Drug Development and Discovery
- 2.3.3 Toxicity Screening
- 2.3.4 Regenerative Medicine
- 2.4 Market Analysis by Regions
- 2.4.1 North America (United States, Canada and Mexico)
- 2.4.1.1 United States Market Status and Outlook (2013-2026)
- 2.4.1.2 Canada Market Status and Outlook (2013-2026)
- 2.4.1.3 Mexico Market Status and Outlook (2013-2026)
- 2.4.2 Europe (Germany, France, UK, Russia and Italy)
- 2.4.2.1 Germany Market Status and Outlook (2013-2026)
- 2.4.2.2 France Market Status and Outlook (2013-2026)
- 2.4.2.3 UK Market Status and Outlook (2013-2026)
- 2.4.2.4 Russia Market Status and Outlook (2013-2026)
- 2.4.2.5 Italy Market Status and Outlook (2013-2026)
- 2.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 2.4.3.1 China Market Status and Outlook (2013-2026)
- 2.4.3.2 Japan Market Status and Outlook (2013-2026)
- 2.4.3.3 Korea Market Status and Outlook (2013-2026)
- 2.4.3.4 India Market Status and Outlook (2013-2026)
- 2.4.3.5 Southeast Asia Market Status and Outlook (2013-2026)
- 2.4.4 South America, Middle East and Africa
- 2.4.4.1 Brazil Market Status and Outlook (2013-2026)
- 2.4.4.2 Egypt Market Status and Outlook (2013-2026)
- 2.4.4.3 Saudi Arabia Market Status and Outlook (2013-2026)
- 2.4.4.4 South Africa Market Status and Outlook (2013-2026)
- 2.4.4.5 Nigeria Market Status and Outlook (2013-2026)
- 2.4.1 North America (United States, Canada and Mexico)
- 2.5 Market Dynamics
- 2.5.1 Market Opportunities
- 2.5.2 Market Risk
- 2.5.3 Market Driving Force
- 2.6 Market Competition News and Trend
- 2.6.1 Merger, Consolidation or Acquisition News
- 2.6.2 Investment or Disinvestment News
- 2.6.3 New Product Development and Launch
3 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2018)
- 3.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Manufacturer (2016-2018)
- 3.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Manufacturer (2016-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Induced Pluripotent Stem Cells (iPSCs) Manufacturer Market Share
- 3.3.2 Top 6 Induced Pluripotent Stem Cells (iPSCs) Manufacturer Market Share
- 3.4 Market Competition Trend
4 Manufacturers Profiles
- 4.1 Fujifilm Holding Corporation (CDI)
- 4.1.1 Business Overview
- 4.1.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.1.2.1 Product A
- 4.1.2.2 Product B
- 4.1.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
- 4.2 ReproCELL
- 4.2.1 Business Overview
- 4.2.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.2.2.1 Product A
- 4.2.2.2 Product B
- 4.2.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
- 4.3 Astellas Pharma Inc
- 4.3.1 Business Overview
- 4.3.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.3.2.1 Product A
- 4.3.2.2 Product B
- 4.3.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
- 4.4 Ncardia
- 4.4.1 Business Overview
- 4.4.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.4.2.1 Product A
- 4.4.2.2 Product B
- 4.4.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
- 4.5 Cell Inspire Biotechnology
- 4.5.1 Business Overview
- 4.5.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.5.2.1 Product A
- 4.5.2.2 Product B
- 4.5.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
- 4.6 Sumitomo Dainippon Pharma
- 4.6.1 Business Overview
- 4.6.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.6.2.1 Product A
- 4.6.2.2 Product B
- 4.6.3 Sumitomo Dainippon Pharma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
- 4.7 Pluricell Biotech
- 4.7.1 Business Overview
- 4.7.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.7.2.1 Product A
- 4.7.2.2 Product B
- 4.7.3 Pluricell Biotech Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
- 4.8 Fate Therapeutics, Inc
- 4.8.1 Business Overview
- 4.8.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
- 4.8.2.1 Product A
- 4.8.2.2 Product B
- 4.8.3 Fate Therapeutics, Inc Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
5 Global Induced Pluripotent Stem Cells (iPSCs) Market Analysis by Regions
- 5.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Regions
- 5.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Regions (2013-2018)
- 5.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Regions (2013-2018)
- 5.2 North America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 5.3 Europe Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 5.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 5.5 South America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 5.6 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
6 North America Induced Pluripotent Stem Cells (iPSCs) by Countries
- 6.1 North America Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
- 6.1.1 North America Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
- 6.1.2 North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
- 6.2 United States Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 6.3 Canada Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 6.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
7 Europe Induced Pluripotent Stem Cells (iPSCs) by Countries
- 7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
- 7.1.1 Europe Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
- 7.1.2 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
- 7.2 Germany Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 7.3 UK Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 7.4 France Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 7.5 Russia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 7.6 Italy Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
8 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) by Countries
- 8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
- 8.1.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
- 8.1.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
- 8.2 China Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 8.3 Japan Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 8.4 Korea Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 8.5 India Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 8.6 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
9 South America Induced Pluripotent Stem Cells (iPSCs) by Countries
- 9.1 South America Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
- 9.1.1 South America Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
- 9.1.2 South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
- 9.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 9.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 9.4 Colombia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
10 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) by Countries
- 10.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
- 10.1.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
- 10.1.2 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
- 10.2 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 10.3 UAE Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 10.4 Egypt Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 10.5 Nigeria Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
- 10.6 South Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
11 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Type
- 11.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Type (2013-2018)
- 11.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Type (2013-2018)
- 11.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Type (2013-2018)
- 11.2 Human iPSCs Sales Growth Rate and Price
- 11.2.1 Global Human iPSCs Sales Growth Rate (2013-2018)
- 11.2.2 Global Human iPSCsPrice (2013-2018)
- 11.3 Mouse iPSCs Sales Growth Rate and Price
- 11.3.1 Global Mouse iPSCs Sales Growth Rate (2013-2018)
- 11.3.2 Global Mouse iPSCs Price (2013-2018)
12 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Application
- 12.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2013-2018)
- 12.2 Academic Research Sales Growth Rate (2013-2018)
- 12.3 Drug Development and Discovery Sales Growth Rate (2013-2018)
- 12.4 Toxicity Screening Sales Growth Rate (2013-2018)
- 12.5 Regenerative Medicine Sales Growth Rate (2013-2018)
13 Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
- 13.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Growth Rate (2019-2026)
- 13.2 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Regions (2019-2026)
- 13.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
- 13.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
- 13.2.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
- 13.2.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
- 13.2.5 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
- 13.3 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2019-2026)
- 13.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Type (2019-2026)
- 13.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2019-2026)
- 13.4 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2019-2026)
- 13.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Application (2019-2026)
- 13.4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2019-2026)
14 Sales Channel, Distributors, Traders and Dealers
- 14.1 Sales Channel
- 14.1.1 Direct Marketing
- 14.1.2 Indirect Marketing
- 14.1.3 Marketing Channel Future Trend
- 14.2 Market Positioning
- 14.2.1 Pricing Strategy
- 14.2.2 Brand Strategy
- 14.2.3 Target Client
- 14.3 Distributors, Traders and Dealers
15 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Induced Pluripotent Stem Cells (iPSCs). Industry analysis & Market Report on Induced Pluripotent Stem Cells (iPSCs) is a syndicated market report, published as Induced Pluripotent Stem Cells (iPSCs)-Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Market Status and Trend Report 2013-2026. It is complete Research Study and Industry Analysis of Induced Pluripotent Stem Cells (iPSCs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
